FOR IMMEDIATE RELEASE
Contact: Donna L. Brock
ATLANTA (April 26, 2016) -‐Clark Atlanta University’s (CAU) Center for Cancer Research and Therapeutic Development (CCRTD) this week received two continuation grants from the National Institutes of Health’s (NIH) National Institute on Minority Health and Health Disparities (NIMHD) totaling $2.75 million. CCRTD Executive Director and Eminent Scholar Shafiq A. Khan, Ph.D., says the funding will allow the center to continue its breakthrough work toward eradicating prostate cancer.
The CCRTD is the nation’s largest academic prostate cancer research enterprise and the only stand-‐alone cancer research center at an HBCU. The Center has invested its energies toward building a comprehensive research and educational program that advances efforts to cure and prevent the disease and mitigate cancer health disparities.
“We know,” Khan says, “that an African-‐American man in his lifetime has approximately a one in five risk of being diagnosed with prostate cancer. The incidence of prostate cancer among U.S. African-‐American males is 65 percent higher, and they are twice as likely to die from the disease as their Caucasian counterparts. Clearly this is a medical issue, but it is also a community and a social health issue.”
A total of $1,624,123 was awarded by the NIH NIMHD’s Research Centers in Minority Institutions Program and will be used for cancer research infrastructure development during this third year of a five-‐year award. A P20 award in the total amount of $1,130,266 will be used to advance the Center of Excellence in Prostate Cancer Research, Education and Community Service, and begins the final year of its five-‐year award cycle. The awards will help ensure that the CCRTD can continue its mission along five crucial tracks: conducting basic research in prostate cancer; training undergraduates, graduate students, junior faculty and post-‐ doctoral fellows in cancer research; competitive recruiting of junior cancer research faculty; and providing year-‐round, targeted outreach programming to educate the African-‐American community about prostate cancer.
“These awards affirm not only the criticality of the research conducted within Clark Atlanta University’s Center for Cancer Research and Therapeutic Development,” CAU President Ronald A. Johnson says, “but also acknowledges the standard of excellence, precision and relentlessness with which the Center’s research agenda is executed. There are few finer examples of this University’s transformation into a global forum for ideas that matter than the CCRTD,” Johnson added.
In addition to being the nation’s largest academic prostate cancer research center, the CCRTD also is the only HBCU member of the Georgia Research Alliance. For more information, visit CCRTDCategory: Research, Administration